ISTH Congress Abstracts

Official abstracts site for the ISTH Congress

MENU 
  • Home
  • Congress Archive
    • ISTH 2022 Congress
    • ISTH 2021 Congress
    • ISTH 2020 Congress
  • Resources
  • Search

Artificial Neural Network for Prediction of Hemorrhagic Severity in Patients with Immune Thrombocytopenia Purpura

L.P. de Carvalho1, M.P. Colella2, J.M. Annichino-Bizzacchi3, T.D. Martins4

1Federal University of São Paulo, Department of Exact and Earth Sciences, Diadema, Brazil, 2University of Campinas - UNICAMP - Brazil, Hematology and Hemotherapy Center, Campinas, Brazil, 3University of Campinas - UNICAMP, Hematology and Hemotherapy Center, Campinas, Brazil, 4Universidade Federal de São Paulo, Departamento de Engenharia Química, Diadema, Brazil

Abstract Number: PB1366

Meeting: ISTH 2020 Congress

Theme: Platelet Disorders and von Willebrand Disease » Acquired Thrombocytopenias

Background: Predict the severity of new bleeding in patients affected by Immune Thrombocytopenia (ITP) is a challenge. There is no consensus on severity of new bleeding in these patients. Therefore, artificial neural networks (ANN) – relating clinical factors with consequences of ITP – may have great potential to assist in treatment.

Aims: To obtain an ANN model capable of predicting the severity of new bleeds based on blood count and patient history.

Methods: Data from 631 C consultations and 631 C+1 consultations – of 118 patients with ITP were collected between 2007 and 2018. Twenty six clinical and laboratorial parameters were considered: sex, age, comorbidities (hypertension, diabetes, pregnancy, neoplasia, chemotherapy or radiotherapy, infection and/or fever, lupus, dyslipidemia, stroke and/or acute myocardial infarction, venous thromboembolism, others), hepatitis B, hepatitis C, HIV, ANF, anticardiolipin, lupus anticoagulant, hemoglobin, erythrocytes, leukocytes, platelets, mean platelet volume, bleeding presence and bleeding severity (between 1 and 5). All these variables considered in C consultation were used as ANN inputs. The bleeding severity in C+1 consultation were used as ANN output. The data were randomly divided into train (70%), test (15%), and validation (15%) data. ANNs with the number of neurons from 5 to 30 were tested, trained with the Levenberg-Marquardt method, and minimizing the mean square error (MSE) between the clinical parameter and the calculated.

Results: The best result was obtained with a two hidden layers ANN, with 25 neurons in both layers. The correlation was 0.8854 (train), 1.0000 (test) and 0.9998 (validation). This model was able to predict severity of new bleeding in 99.21% of cases with a relative error less than 1%.

Conclusions: The results obtained show that ANN have great potential to assist in the treatment of ITP, and must be refined and validate in other group of patients to be used in clinical practice.

To cite this abstract in AMA style:

de Carvalho LP, Colella MP, Annichino-Bizzacchi JM, Martins TD. Artificial Neural Network for Prediction of Hemorrhagic Severity in Patients with Immune Thrombocytopenia Purpura [abstract]. Res Pract Thromb Haemost. 2020; 4 (Suppl 1). https://abstracts.isth.org/abstract/artificial-neural-network-for-prediction-of-hemorrhagic-severity-in-patients-with-immune-thrombocytopenia-purpura/. Accessed October 1, 2023.

« Back to ISTH 2020 Congress

ISTH Congress Abstracts - https://abstracts.isth.org/abstract/artificial-neural-network-for-prediction-of-hemorrhagic-severity-in-patients-with-immune-thrombocytopenia-purpura/

Simple Search

Supported By:

Takeda logo

ISTH 2022 Congress site

Visit the official web site for the ISTH 2022 Virtual Congress »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2023 John Wiley & Sons, Inc. All Rights Reserved.
Wiley